Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 8.95
+0.85 (10.49%)
Last updated: Dec 5, 2025, 4:16 PM CET
Vytrus Biotech Revenue
Vytrus Biotech had revenue of 3.06M EUR in the half year ending December 31, 2024, with 46.56% growth. This brings the company's revenue in the last twelve months to 8.09M, up 54.38% year-over-year. In the year 2024, Vytrus Biotech had annual revenue of 6.09M with 29.51% growth.
Revenue (ttm)
8.09M
Revenue Growth
+54.38%
P/S Ratio
7.91
Revenue / Employee
218.52K
Employees
37
Market Cap
63.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.09M | 1.39M | 29.51% |
| Dec 31, 2023 | 4.70M | 219.70K | 4.90% |
| Dec 31, 2022 | 4.48M | 968.83K | 27.57% |
| Dec 31, 2021 | 3.51M | 1.28M | 57.47% |
| Dec 31, 2020 | 2.23M | 456.81K | 25.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.09B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Faes Farma | 571.12M |
| Laboratorio Reig Jofre | 330.34M |
| Clínica Baviera | 296.76M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |